First test of new Weight-Loss shot begins in humans
NCT ID NCT07219589
Summary
This is the first study in humans to test the safety of a new experimental injection called HM17321, which is being developed for obesity. About 40 healthy adults will receive a single injection to see how their bodies react and process the drug. The main goal is to check for side effects and determine safe dosage levels before testing in people with obesity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medpace Clinical Pharmacology Unit
RECRUITINGCincinnati, Ohio, 45227, United States
Contact
Conditions
Explore the condition pages connected to this study.